Tumour Reactions to Hypoxia

被引:38
|
作者
Voss, M. J. [1 ]
Niggemann, B. [1 ]
Zaenker, K. S. [1 ]
Entschladen, F. [1 ]
机构
[1] Univ Witten Herdecke, Inst Immunol, D-58448 Witten, Germany
关键词
Hypoxia; angiogenesis; lymphangiogenesis; neoneurogenesis; metabolic shift; cell migration; metastasis formation; ENDOTHELIAL GROWTH-FACTOR; LYMPH-NODE METASTASIS; INDUCIBLE FACTOR-I; PERINEURAL INVASION; GENE-EXPRESSION; PROGNOSTIC-SIGNIFICANCE; NEUROTROPHIC FACTORS; INDUCED MIGRATION; CANCER CELLS; FACTOR VEGF;
D O I
10.2174/156652410791317020
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Fast growing solid tumours generally lack an inner organisation, which causes the problem of a sufficient nutrient of each part of the tumour that then happens only by diffusion. The low oxygen supply leads to the activation of hypoxia-inducible factors, which regulate a plethora of genes. The reaction of tumour cells to hypoxia can be divided into two parts: On the one hand, there are signal substances, predominantly growth factors and cytokines, which provoke the vascularisation (angiogenesis), lymph vessel development (lymphangiogenesis), and the innervation (neoneurogenesis) of tumours and thus connect the tumour to structures of the environment. On the other hand, genes for intracellular proteins and receptors are regulated, which lead to changes of the tumour cell functions. Best characterised is the metabolic shift, a high anaerobic glycolytic activity and simultaneously a reduction of respiration. Furthermore, proliferation, dedifferentiation, resistance to apoptosis, and the metastatic potential are affected. With regard to the latter, we herein show that the migratory activity and velocity of PC-3 human prostate carcinoma cells significantly increase under oxygen-deprivation, which might be an explanation for the increasing number of experimental and clinical hints, that an anti-angiogenic therapy can promote the metastasis formation.
引用
收藏
页码:381 / 386
页数:6
相关论文
共 50 条
  • [21] Tumour hypoxia as a predictor for radiation therapy
    Harada, H.
    RADIOTHERAPY AND ONCOLOGY, 2023, 182 : S710 - S711
  • [22] Targeting tumour hypoxia in breast cancer
    Milani, Manuela
    Harris, Adrian L.
    EUROPEAN JOURNAL OF CANCER, 2008, 44 (18) : 2766 - 2773
  • [23] FDG uptake, a surrogate of tumour hypoxia?
    Dierckx, Rudi Andre
    de Wiele, Christophe Van
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2008, 35 (08) : 1544 - 1549
  • [24] Imaging tumour hypoxia: where are we?
    Van de Wiele, C
    Signore, A
    Scopinaro, F
    Waterhouse, R
    Dierckx, RA
    NUCLEAR MEDICINE COMMUNICATIONS, 2001, 22 (09) : 945 - 947
  • [25] FDG uptake, a surrogate of tumour hypoxia?
    Rudi Andre Dierckx
    Christophe Van de Wiele
    European Journal of Nuclear Medicine and Molecular Imaging, 2008, 35 : 1544 - 1549
  • [26] Hypoxia and cellular metabolism in tumour pathophysiology
    Parks, Scott K.
    Cormerais, Yann
    Pouyssegur, Jacques
    JOURNAL OF PHYSIOLOGY-LONDON, 2017, 595 (08): : 2439 - 2450
  • [27] The remarkable yin and yang of tumour hypoxia
    Brown, Martin
    INTERNATIONAL JOURNAL OF RADIATION BIOLOGY, 2010, 86 (11) : 907 - 917
  • [28] Tumour hypoxia, metabolism and nutritional stress
    Pouyssegur, J.
    JOURNAL OF VASCULAR RESEARCH, 2011, 48 : 183 - 183
  • [29] Hypoxia-mediated tumour targeting
    K Binley
    Z Askham
    L Martin
    H Spearman
    D Day
    S Kingsman
    S Naylor
    Gene Therapy, 2003, 10 : 540 - 549
  • [30] Exploiting tumour hypoxia in cancer treatment
    J. Martin Brown
    William R. Wilson
    Nature Reviews Cancer, 2004, 4 : 437 - 447